Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,166.51
-16.11 (-1.36%)
At close: Oct 13, 2026, 4:00 PM EDT
1,173.00
+6.49 (0.56%)
Pre-market: Oct 14, 2026, 7:02 AM EDT
Eli Lilly Stock Forecast
Stock Price Forecast
According to 30 analysts polled by S&P Global, Eli Lilly stock has a consensus rating of "Buy" and an average price target of $1,330. The average 1-year stock price forecast is 14.03% higher than the current stock price, while the lowest is $930 (-20.28%) and the highest is $1,600 (+37.16%).
Price Target: $1,330 (+14.03%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eli Lilly stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 18 | 17 | 17 | 18 | 19 | 19 |
| Buy | 6 | 6 | 5 | 6 | 6 | 6 |
| Hold | 5 | 5 | 4 | 4 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 31 | 30 | 28 | 30 | 30 | 30 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $1,400 | Buy | Maintains | $1,400 | +20.02% | Oct 12, 2026 |
| Citi | Citi | Buy Maintains $1,600 | Buy | Maintains | $1,600 | +37.16% | Oct 12, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $1,500 | Buy | Maintains | $1,500 | +28.59% | Oct 12, 2026 |
| Barclays | Barclays | Buy Maintains $1,400 | Buy | Maintains | $1,400 | +20.02% | Oct 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $1,500 | Buy | Maintains | $1,500 | +28.59% | Oct 9, 2026 |
Financial Forecast
Revenue This Year
88.59B
from 65.18B
Increased by 35.91%
Revenue Next Year
102.45B
from 88.59B
Increased by 15.65%
EPS This Year
35.36
from 24.21
Increased by 46.06%
EPS Next Year
47.66
from 35.36
Increased by 34.78%
EPS and Forward PE are based on non-GAAP adjusted numbers.